SEQUENTIAL DERMAL MICROVASCULAR AND PERIVASCULAR CHANGES IN THE DEVELOPMENT OF SCLERODERMA

被引:315
作者
PRESCOTT, RJ [1 ]
FREEMONT, AJ [1 ]
JONES, CJP [1 ]
HOYLAND, J [1 ]
FIELDING, P [1 ]
机构
[1] UNIV MANCHESTER,DEPT PATHOL,MANCHESTER M13 9PL,LANCS,ENGLAND
关键词
SYSTEMIC SCLEROSIS; DERMAL MICROVASCULATURE; DERMAL FIBROSIS;
D O I
10.1002/path.1711660307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has been previously proposed that there is a primary microvascular abnormality in patients with systemic sclerosis. In this study using conventional light and electron microscopy, immunohistochemistry, and labelled adenosine uptake techniques, changes in the dermal microvasculature have been related to the various clinical stages of skin disease in systemic sclerosis. The earliest pathological changes are seen in clinically normal skin. They constitute changes in endothelial cell function and their consequences. Perivascular oedema is an early feature. With progression in the clinical disease, there is, at first, an inflammatory cell infiltrate into the dermis, particularly the papillary and mid-dermis, and platelet aggregation within vessels. Further clinical progression is associated with increasing dermal fibrosis, loss of adnexae, and vascular effacement. It is postulated that the recruitment of different types of mononuclear cells into the dermis is causally linked with the preceding endothelial cell dysfunction and the subsequent induction of fibroblast proliferation and collagen synthesis.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 42 条
[1]  
ANDREWS BS, 1986, J RHEUMATOL, V13, P341
[2]   MAST-CELLS AND FIBROSIS [J].
ATKINS, FM ;
CLARK, RAF .
ARCHIVES OF DERMATOLOGY, 1987, 123 (02) :191-193
[3]  
CABRAL A, 1983, ARTHRITIS RHEUM, V26, P1352
[4]   FINE-STRUCTURAL CAPILLARY CHANGES AND BASAL LAMINA THICKENING IN SCLERODERMA (PROGRESSIVE SYSTEMIC-SCLEROSIS) AND RAYNAUDS DISEASE [J].
CAMILLERI, JP ;
FIESSINGER, JN ;
DEBURE, C ;
BRUNEVAL, P ;
TRICOTTET, V ;
KAZANDJIAN, S ;
HOUSSET, E .
PATHOLOGY RESEARCH AND PRACTICE, 1984, 178 (03) :230-236
[5]   MAST-CELLS, T-CELLS AND ABNORMAL FIBROSIS [J].
CLAMAN, HN .
IMMUNOLOGY TODAY, 1985, 6 (06) :192-195
[6]   CYTO-TOXICITY OF SERA FROM PATIENTS WITH SCLERODERMA - EFFECTS ON HUMAN-ENDOTHELIAL CELLS AND FIBROBLASTS IN CULTURE [J].
COHEN, S ;
JOHNSON, AR ;
HURD, E .
ARTHRITIS AND RHEUMATISM, 1983, 26 (02) :170-178
[7]   INTERLEUKIN-1 INHIBITS THE SYNTHESIS OF VONWILLEBRAND-FACTOR IN ENDOTHELIAL-CELLS, WHICH RESULTS IN A DECREASED REACTIVITY OF THEIR MATRIX TOWARD PLATELETS [J].
DEGROOT, PG ;
VERWEIJ, CL ;
NAWROTH, PP ;
DEBOER, HC ;
STERN, DM ;
SIXMA, JJ .
ARTERIOSCLEROSIS, 1987, 7 (06) :605-611
[8]  
DRENK F, 1988, J RHEUMATOL, V15, P468
[9]   TRANSFORMING GROWTH-FACTOR-BETA - SELECTIVE INCREASE IN GLYCOSAMINOGLYCAN SYNTHESIS BY CULTURES OF FIBROBLASTS FROM PATIENTS WITH PROGRESSIVE SYSTEMIC-SCLEROSIS [J].
FALANGA, V ;
TIEGS, SL ;
ALSTADT, SP ;
ROBERTS, AB ;
SPORN, MB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 89 (01) :100-104
[10]   IMMUNOFLUORESCENCE ANALYSIS OF COLLAGEN, FIBRONECTIN, AND BASEMENT-MEMBRANE PROTEIN IN SCLERODERMA SKIN [J].
FLEISCHMAJER, R ;
DESSAU, W ;
TIMPL, R ;
KRIEG, T ;
LUDERSCHMIDT, C ;
WIESTNER, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1980, 75 (03) :270-274